Summer cutting edge treatments update: 2015
Collapse
X
-
There will be a serious cure out in the next 5 years but it probably won't come from any of the entities mentioned in your list.
There are many research teams working on anti-aging, tissue regeneration, etc..... luckily, even though these researchers are not specifically looking to cure MPB, their research in anti-aging and tissue regenration/stem cells will indirectly provide the technology/insight needed to cure MPB.
If you go look through one academic tissue regeneration journal for just one month, you'll see there is an immense amount of research going on that is not mentioned anywhere on the forums.
TL;DR: There is a lot going on beyond histogen and replicel -
Thanks for the update. So what would be the ideal most effective stack now for halting, regrowth and thickness?
OC
low dose RU (20 or 30mg)
neogenic
adenogenLeave a comment:
-
-
-
lol 6 more years for CB, an Italian based topical AA? That's literally useless for every single person on this board.Leave a comment:
-
lol @ HAIR BEAR "5-10"I sincerely hope so but lets not forget that in past Replicel have been guilty of exaggeration themselves and things can change quite suddenly, I guess after you have been around the block a few times within this timeless 5-10 year cycles you start to take these estimations with much more skepticism than most.
The greatest thing to happen with absolute certainty has been the streamlined approach to the testing and approval process which would presumably accelerate discoveries and science as a whole.
The same process may be adopted in the United States (being put forward now) is a big step in the right direction and will open the door to a larger group of researchers and scientists and wealth in the United States but having said that everything takes a while to trickle down worldwide and also market so we must not get up our hopes.
I'm sorry if I sound pessimistic that is not the intention I am just trying remain realistic.
Thanks for the round up though.
Leave a comment:
-
I sincerely hope so but lets not forget that in past Replicel have been guilty of exaggeration themselves and things can change quite suddenly, I guess after you have been around the block a few times within this timeless 5-10 year cycles you start to take these estimations with much more skepticism than most.@Hair Bear: Please, don't exaggerate. Replicel company confirmed date 2018 in Japan even after their delays with phase II. If it works as they claim, we will be saved with it and good HT.
We don't know nothing about real state of Histogen and Follica, we may be surprised by them.
When it comes to Seti and other drugs - new law regulations in USA may considerably shorten the process of their commercialisation.
The greatest thing to happen with absolute certainty has been the streamlined approach to the testing and approval process which would presumably accelerate discoveries and science as a whole.
The same process may be adopted in the United States (being put forward now) is a big step in the right direction and will open the door to a larger group of researchers and scientists and wealth in the United States but having said that everything takes a while to trickle down worldwide and also market so we must not get up our hopes.
I'm sorry if I sound pessimistic that is not the intention I am just trying remain realistic.
Thanks for the round up though.
Leave a comment:
-
21st century cure bill might change the phase 3 timeline of some of them if we're lucky.
And japanese stem cell treatments can have approval after just safety proof!! Japan's travelling is our future hahaLeave a comment:
-
-
-
@Hair Bear: Please, don't exaggerate. Replicel company confirmed date 2018 in Japan even after their delays with phase II. If it works as they claim, we will be saved with it and good HT.
We don't know nothing about real state of Histogen and Follica, we may be surprised by them.
When it comes to Seti and other drugs - new law regulations in USA may considerably shorten the process of their commercialisation.Leave a comment:
-
Good post!Here we go, typical summer thread for listing potential treatments in the future.
1. CB from Cosmo, poc finishes this fall and we should know results then or within 12 months of the trial finishing, they plan to release CB in 2021
2. SM, just came out of nowhere this last year, they finish a massive phase II dose ranging study this fall as well, we should know results within 12 prior.
3. Bim, no one knows what is going on, but they are forced to release results 12 months after the conclusion of the trial so we should know the results by January at the latest.
4. Histogen, in series D financing, I'd say it's safe to say they're dead and just haven't admitted it yet.
5. Replicel, getting everything postponed, they aim to start phase IIb dosing the end of this year or beginning of the next. Shiseido should be starting their own trials using the replicel technology this year though, could be released in Asia in 2018-2019
6. Kythera's setipiprant, was work from Dr. Cots at Penn, their company was recently acquired by Allergen, so who knows if this will be delayed but they aim to start poc trials early 2016
7. Dr. Cole is doing a research study that has just started on various techniques for PRP therapy
8. Dr. Wesley just began phase testing of 100-200 grafts using his Piloscopic device
Overall, it will be probably 5 years before we see one of these drugs hit the market, but we have more players in the game right now than ever. In the short term, hopefully Dr. Cole can prove there is some merit to these PRP techniques and hopefully Dr. Wesley can begin using his instrument in practice, and getting regeneration with it.
You say histogen is dead? could you please post the link where you see the Financial problems,etc..?Leave a comment:
-
PiloFocus should be good in 2017.Here we go, typical summer thread for listing potential treatments in the future.
1. CB from Cosmo, poc finishes this fall and we should know results then or within 12 months of the trial finishing, they plan to release CB in 2021
2. SM, just came out of nowhere this last year, they finish a massive phase II dose ranging study this fall as well, we should know results within 12 prior.
3. Bim, no one knows what is going on, but they are forced to release results 12 months after the conclusion of the trial so we should know the results by January at the latest.
4. Histogen, in series D financing, I'd say it's safe to say they're dead and just haven't admitted it yet.
5. Replicel, getting everything postponed, they aim to start phase IIb dosing the end of this year or beginning of the next. Shiseido should be starting their own trials using the replicel technology this year though, could be released in Asia in 2018-2019
6. Kythera's setipiprant, was work from Dr. Cots at Penn, their company was recently acquired by Allergen, so who knows if this will be delayed but they aim to start poc trials early 2016
7. Dr. Cole is doing a research study that has just started on various techniques for PRP therapy
8. Dr. Wesley just began phase testing of 100-200 grafts using his Piloscopic device
Overall, it will be probably 5 years before we see one of these drugs hit the market, but we have more players in the game right now than ever. In the short term, hopefully Dr. Cole can prove there is some merit to these PRP techniques and hopefully Dr. Wesley can begin using his instrument in practice, and getting regeneration with it.Leave a comment:

Leave a comment: